StatLab
Lance Mikus, MBA, currently serves as Vice President of Marketing and Product Management at StatLab, where the focus is on enhancing commercial growth in the anatomic pathology market. As the President and Owner of PlugShields, Lance established a company aimed at solving issues related to tripping GFCIs in outdoor home entertainment. Previously, as Head of Product Management at Elephas, Lance worked on advancing patient-derived live tumor fragment technology for cancer therapy predictions. With over a decade at Danaher Corporation, Lance held several roles including Director of Product Management for Imaging Solutions, achieving significant sales growth and regulatory milestones in digital pathology. Earlier experience includes global marketing leadership at Life Technologies and scientific research at the UW School of Medicine and Public Health, supported by an MBA from the Wisconsin School of Business.
This person is not in the org chart
This person is not in any offices
StatLab
StatLab is a leading specialty supplier exclusively focused on providing histology, cytology and immunohistochemistry consumable supplies to more than 3,000 anatomic pathology laboratories throughout the United States. Our foundation is rooted in customer service excellence and we recognize that product cost is but one aspect of the total value stream. Being able to offer consistent, reliable, and error-free service minimizes the total cost of doing business with StatLab and requires prioritization of service excellence throughout the organization. Continuous improvement efforts have resulted in a 98.1% same day fill rate, a 99.8% order accuracy rate, and an average “on-hold” wait time of less than 10 seconds when calling our customer service department. These are just some of the reasons we are the fastest growing histology consumable provider in the industry. Our purpose reflects the role we think we play: To enable our customers to provide cost-effective patient care. We take pride in the fact that we help our customers help patients by providing them with (1) high-quality products (consistent, reliable, and predictable), (2) delivered on time and (3) at a fair price. 1+2+3 = “cost-effective”.